Taysha Gene Therapies, Inc.
TSHA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001806310
In the last 90 days, Taysha Gene Therapies, Inc. insiders filed 0 open-market purchases and 1 sale; 208 institutions reported holding it in 13F filings for Q2 2026, worth $2.03B in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Taysha Gene Therapies, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 109 | 107 | −2 |
| Shares | 140.2M | 158.2M | +18.0M (+12.8%) |
| Value | $402.2M | $354.3M | −$47.9M (−11.9%) |
New holders (36)
Institutions that held Taysha Gene Therapies, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
Sold out (38)
Institutions that held Taysha Gene Therapies, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.